Bone Marrow Failure Disorders

Coronavirus Disease COVID-19: EBMT Recommendations Version 15

While the management of COVID-19 continues to evolve, these February 2021 recommendations from EBMT provide useful guidance on stem cell transplant (HCT) in the context of COVID-19. The guidelines will be updated as new information becomes available regarding the impact of COVID-19 epidemiology and clinical outcome on recipients of HCT.

European Group for Blood and Marrow Transplantation